Nitric Oxide (NO) and Cyclooxygenase-2 (COX-2) Cross-Talk in Co-Cultures of Tumor Spheroids with Normal Cells
Authors:
Open Access
- 22 February 2011
- journal article
- research article
- Published by Springer Nature in Cancer Microenvironment
- Vol. 4 (2) , 187-198
Abstract
Cyclooxygenases (COX), prostaglandin E2 (PGE2) and nitric oxide (NO) are believed to be some of the most important factors related to colon cancer growth and metastasis. In this study, we aimed to investigate the associations between COX-2, PGE2 and NO in co-cultures of human colon cancer spheroids obtained from different tumor grades with normal human colonic epithelium and myofibroblast monolayers. L-arginine (2 mM), a substrate for nitric oxide synthases (NOS), decreased COX-2 and PGE2 levels, while NG-nitro-L-arginine methyl ester (L-NAME) (2 mM), a NOS inhibitor, had no influence on COX-2 and PGE2 levels but limited tumor cell motility. NS398 (75 μM), a selective COX-2 inhibitor, had no significant influence on NO level but decreased motility of tumor cells. COX-2, PGE2 and NO levels depended on the tumor grade of the cells, being the highest in Duke’s stage III colon carcinoma. Summing up, we showed that addition of L-arginine at doses which did not stimulate NO level caused a significant decrease in COX-2 and PGE2 amounts in co-cultures of colon tumor spheroids with normal epithelial cells and myofibroblasts. Any imbalances in NO level caused by exogenous factors influence COX-2 and PGE2 amounts depending on the kind of cells, their reciprocal interactions and the local microenvironmental conditions. The knowledge of these effects may be useful in limiting colon carcinoma progression and invasion.Keywords
This publication has 49 references indexed in Scilit:
- Rapamycin suppresses TLR4-triggered IL-6 and PGE2 production of colon cancer cells by inhibiting TLR4 expression and NF-κB activationMolecular Immunology, 2008
- l-Arginine Reduces Cell Proliferation and Ornithine Decarboxylase Activity in Patients with Colorectal Adenoma and AdenocarcinomaClinical Cancer Research, 2007
- Pathways Mediating the Expansion and Immunosuppressive Activity of Myeloid-Derived Suppressor Cells and Their Relevance to Cancer TherapyClinical Cancer Research, 2007
- Aldose reductase regulates TNF-α-induced PGE2 production in human colon cancer cellsCancer Letters, 2007
- Cyclooxygenase II:A Molecular Target for Colorectal Cancer Prevention and Treatment?Annals of Cancer Research and Therapy, 2007
- COX-2 inhibition as a tool to treat and prevent colorectal cancerCritical Reviews in Oncology/Hematology, 2004
- Nitric oxide signaling in colon cancer chemopreventionMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2004
- Induction of intestinal damage by rofecoxib, the selective COX-2 inhibitor, under inhibition of nitric oxide production in ratsInflammopharmacology, 2002
- Host Response to Infection: the Role of CpG DNA in Induction of Cyclooxygenase 2 and Nitric Oxide Synthase 2 in Murine MacrophagesInfection and Immunity, 2001
- Systemic Administration of Nω-Nitro-l-Arginine Methyl Ester and Indomethacin Reduces the Elevation of Brain PGE2Content and Prevents Seizures and Hippocampal Damage Evoked by LiCl and Tacrine in RatExperimental Neurology, 1998